Joseph A. Sparano, MD, FACP, has been named chief of hematology and medical oncology at Mount Sinai Well being System.
Sparano additionally will function deputy director of The Tisch Most cancers Institute and maintain the Ezra M. Greenspan, MD professorship in medical most cancers therapeutics at Icahn College of Medication.
Sparano is acknowledged for his experience within the administration of breast most cancers and HIV-associated malignancies.
Joseph A. Sparano
“Dr. Sparano brings a wealth of expertise in medical, analysis and academic excellence,” Ramon Parsons, MD, PhD, director of The Tisch Most cancers Institute, chair of oncological sciences, and Ward-Coleman chair in most cancers analysis at Icahn Mount Sinai, stated in a press launch. “He will probably be instrumental in increasing Mount Sinai’s footprint in most cancers developments, fostering our mission of offering superior most cancers care with particular consideration to fairness, and guiding the establishment’s progress towards NCI Complete Most cancers Middle standing.”
Sparano spent 33 years at Albert Einstein Faculty of Medication and Montefiore Medical Middle, the place he served as professor of medication; professor of obstetrics, gynecology and ladies’s well being; affiliate chairman for medical analysis within the division of oncology; and affiliate director for medical analysis at Albert Einstein Most cancers Middle. He additionally served as chief of the part of breast medical oncology since 1995 and affiliate chairman of medical oncology since 2001.
Sparano is chair and principal investigator of the AIDS Malignancy Consortium. He has performed research designed to enhance outcomes of HIV-positive people with most cancers, together with these with non-Hodgkin lymphoma or anal most cancers.